| 1 |
gemcitabine
(1165 times)
|
Neoplasms
(639 times)
|
OS (98 times)
5-FU (75 times)
NSCLC (74 times)
|
1994 Weekly gemcitabine in advanced or metastatic solid tumors. A clinical phase I study.
|
| 2 |
genetically engineered mouse
(148 times)
|
Neoplasms
(57 times)
|
NF1 (10 times)
PDAC (9 times)
PCa (4 times)
|
2000 The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.
|
| 3 |
gaseous elemental mercury
(86 times)
|
Environmental Health
(76 times)
|
RGM (17 times)
GOM (16 times)
PBM (11 times)
|
2003 Springtime depletion of mercury in the European Arctic as observed at Svalbard.
|
| 4 |
glycolipid-enriched membrane
(59 times)
|
Biochemistry
(23 times)
|
cld7 (3 times)
GPI (3 times)
TJ (3 times)
|
1996 Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains.
|
| 5 |
gemfibrozil
(58 times)
|
Toxicology
(19 times)
|
CBZ (5 times)
PP (4 times)
PPARalpha (4 times)
|
1989 Quantitative assessment of enzyme induction by peroxisome proliferators and application to determination of effects on triglyceride biosynthesis in primary cultures of rat hepatocytes.
|
| 6 |
geriatric evaluation and management
(52 times)
|
Geriatrics
(37 times)
|
CI (5 times)
ADL (4 times)
UPC (4 times)
|
1991 Impacts of geriatric evaluation and management programs on defined outcomes: overview of the evidence.
|
| 7 |
Gram-positive enhancer matrix
(36 times)
|
Microbiology
(9 times)
|
PA (8 times)
LAB (3 times)
LysM (2 times)
|
2006 Novel surface display system for proteins on non-genetically modified gram-positive bacteria.
|
| 8 |
genetically engineered microorganism
(31 times)
|
Environmental Health
(17 times)
|
MBR (4 times)
CAS (3 times)
HRT (2 times)
|
1991 Monitoring survival and gene transfer in soil microcosms of recombinant Escherichia coli designed to represent an industrial production strain.
|
| 9 |
Genes in Myopia
(23 times)
|
Ophthalmology
(12 times)
|
ATR (6 times)
DZ (4 times)
MZ (4 times)
|
2005 Methodology and recruitment of probands and their families for the Genes in Myopia (GEM) Study.
|
| 10 |
gemcitabine hydrochloride
(22 times)
|
Neoplasms
(10 times)
|
PLGA (2 times)
5-FU (1 time)
BCa (1 time)
|
2004 Surgical resection deteriorates gemcitabine-induced leukopenia in pancreatic cancer.
|
| 11 |
genome-scale metabolic model
(20 times)
|
Biotechnology
(7 times)
|
ADI (1 time)
Arg (1 time)
AT (1 time)
|
2014 A model-driven quantitative metabolomics analysis of aerobic and anaerobic metabolism in E. coli K-12 MG1655 that is biochemically and thermodynamically consistent.
|
| 12 |
gaseous elemental Hg
(18 times)
|
Environmental Health
(17 times)
|
MDF (2 times)
TGM (2 times)
CFPP (1 time)
|
2004 Speciation and mass-balance of mercury from pulverized coal fired power plants burning western Canadian subbituminous coals.
|
| 13 |
Guideline Elements Model
(16 times)
|
Medical Informatics
(16 times)
|
CPG (2 times)
CPGs (2 times)
AICG (1 time)
|
2000 GEM: a proposal for a more comprehensive guideline document model using XML.
|
| 14 |
gas electron multiplier
(14 times)
|
Nuclear Medicine
(8 times)
|
TEPC (5 times)
EAST (1 time)
PHS (1 time)
|
2004 First microdosimetric measurements with a TEPC based on a GEM.
|
| 15 |
Genes, Environment, and Melanoma
(14 times)
|
Neoplasms
(6 times)
|
AJCC (3 times)
CI (2 times)
HR (2 times)
|
2012 Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas.
|
| 16 |
Ginkgo Evaluation of Memory
(12 times)
|
Geriatrics
(4 times)
|
CI (3 times)
CDR (2 times)
HR (2 times)
|
2006 The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.
|
| 17 |
goal equivalent manifold
(10 times)
|
Physiology
(5 times)
|
CNSLBP (1 time)
COM (1 time)
EMG (1 time)
|
2006 Body-goal variability mapping in an aiming task.
|
| 18 |
gemcitabine monotherapy
(9 times)
|
Neoplasms
(5 times)
|
ORR (2 times)
OS (2 times)
Pca (2 times)
|
2004 Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate.
|
| 19 |
Gaussian electrostatic model
(8 times)
|
Chemistry
(5 times)
|
QM/MM (2 times)
EDA (1 time)
FFP (1 time)
|
2006 Quantum mechanics/molecular mechanics electrostatic embedding with continuous and discrete functions.
|
| 20 |
Gender Empowerment Measure
(8 times)
|
Public Health
(2 times)
|
GDP (3 times)
CI (2 times)
GDI (2 times)
|
2004 Gender and culture differences in emotion.
|
| 21 |
gene expression model
(8 times)
|
Neoplasms
(2 times)
|
CDS (1 time)
GE (1 time)
GES (1 time)
|
2008 Analyzing M-CSF dependent monocyte/macrophage differentiation: expression modes and meta-modes derived from an independent component analysis.
|
| 22 |
general emergency medicine
(8 times)
|
Pediatrics
(7 times)
|
PEM (7 times)
ED (4 times)
CI (2 times)
|
1997 Factors influencing termination of resuscitative efforts in children: a comparison of pediatric emergency medicine and adult emergency medicine physicians.
|
| 23 |
Graduate Entry Medicine
(8 times)
|
Education
(4 times)
|
CAP (1 time)
CI (1 time)
DEM (1 time)
|
2007 Graduate entry medicine: high aspirations at birth.
|
| 24 |
Gender Equitable Men
(7 times)
|
Public Health
(4 times)
|
SRPS (2 times)
AOR (1 time)
CHARM (1 time)
|
2006 Challenging and changing gender attitudes among young men in Mumbai, India.
|
| 25 |
gemifloxacin
(6 times)
|
Anti-Bacterial Agents
(2 times)
|
CIP (3 times)
GAT (3 times)
LEV (2 times)
|
2000 Gemifloxacin and ciprofloxacin pharmacodynamics in an in-vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and doses.
|
| 26 |
gemcitabine alone
(5 times)
|
Neoplasms
(3 times)
|
ABC-02 (1 time)
BTC (1 time)
CI (1 time)
|
2002 Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma.
|
| 27 |
gene expression microarray
(5 times)
|
Neoplasms
(4 times)
|
BLBC (1 time)
CUP (1 time)
DEGs (1 time)
|
2004 Predicting biomarkers for ovarian cancer using gene-expression microarrays.
|
| 28 |
generalized expectation maximization
(5 times)
|
Medical Informatics
(2 times)
|
BWT (1 time)
GSM (1 time)
LRMF (1 time)
|
1989 A generalized EM algorithm for 3-D Bayesian reconstruction from Poisson data using Gibbs priors.
|
| 29 |
genome-scale metabolic network model
(5 times)
|
Microbiological Phenomena
(1 time)
|
Tn-seq (1 time)
TSAS (1 time)
|
2015 Applications of genome-scale metabolic network model in metabolic engineering.
|
| 30 |
Germline-encoded mycolyl lipid-reactive
(5 times)
|
Allergy and Immunology
(3 times)
|
TCRs (3 times)
GMM (1 time)
MAIT (1 time)
|
2013 A conserved human T cell population targets mycobacterial antigens presented by CD1b.
|
| 31 |
Germplasm Enhancement of Maize
(5 times)
|
Botany
(2 times)
|
CA (1 time)
CMLs (1 time)
COMT (1 time)
|
2012 Genetic characterization of a core set of a tropical maize race Tuxpeno for further use in maize improvement.
|
| 32 |
Gestational Diabetes' Effects on Moms
(5 times)
|
Endocrinology
(2 times)
|
GDM (2 times)
CI (1 time)
DPP (1 time)
|
2014 A pragmatic cluster randomized clinical trial of diabetes prevention strategies for women with gestational diabetes: design and rationale of the Gestational Diabetes' Effects on Moms (GEM) study.
|
| 33 |
GreenFeed emission monitoring
(5 times)
|
Veterinary Medicine
(3 times)
|
DMP (2 times)
MY (2 times)
RC (2 times)
|
2015 Estimating daily methane production in individual cattle with irregular feed intake patterns from short-term methane emission measurements.
|
| 34 |
Growth and Empowerment Measure
(5 times)
|
Public Health
(2 times)
|
FWB (1 time)
|
2010 Psychometric validation of the Growth and Empowerment Measure (GEM) applied with Indigenous Australians.
|
| 35 |
gel extrusion module
(4 times)
|
Pharmacology
(3 times)
|
DMA (1 time)
SHS-GC (1 time)
|
2002 Static headspace gas chromatographic analysis of the residual solvents in gel extrusion module tablet formulations.
|
| 36 |
Genetically Engineered Mice
(4 times)
|
Pathology
(2 times)
|
MMTV (1 time)
mPIN (1 time)
|
2001 Validity of mouse mammary tumour models for human breast cancer: comparative pathology.
|
| 37 |
GEnomic Multi-tool
(4 times)
|
Clinical Laboratory Techniques
(2 times)
|
---
|
2012 Fast computation and applications of genome mappability.
|
| 38 |
Global Evidence Mapping
(4 times)
|
Medicine
(2 times)
|
TBI (3 times)
ERABI (2 times)
SCI (2 times)
|
2011 The Global Evidence Mapping Initiative: scoping research in broad topic areas.
|
| 39 |
Grid-Enabled Measures
(4 times)
|
Medical Informatics
(1 time)
|
NCI (3 times)
caDSR (2 times)
CDE (1 time)
|
2011 Grid-enabled measures: using Science 2.0 to standardize measures and share data.
|
| 40 |
group epitope mapping
(4 times)
|
Molecular Biology
(2 times)
|
STD (3 times)
CAPs (1 time)
GEM-CRL (1 time)
|
2001 Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor.
|
| 41 |
GTP binding protein overexpressed in skeletal muscle
(4 times)
|
Pathology
(1 time)
|
CXCR7 (1 time)
HCC (1 time)
IMF (1 time)
|
2010 A systemic network for Chlamydia pneumoniae entry into human cells.
|
| 42 |
Generalized Evaporation Model
(3 times)
|
Nuclear Medicine
(2 times)
|
JQMD (2 times)
PHITS (2 times)
QMD (1 time)
|
2005 Simulations of an accelerator-based shielding experiment using the particle and heavy-ion transport code system PHITS.
|
| 43 |
genome-scale model
(3 times)
|
Biotechnology
(3 times)
|
FBA (1 time)
Mtb (1 time)
TB (1 time)
|
2013 Basic and applied uses of genome-scale metabolic network reconstructions of Escherichia coli.
|
| 44 |
Genome-scale models of metabolism
(3 times)
|
Biotechnology
(2 times)
|
FBA (2 times)
ACT (1 time)
eMOMA (1 time)
|
2016 Transcriptomics-based strain optimization tool for designing secondary metabolite overproducing strains of Streptomyces coelicolor.
|
| 45 |
geriatric emergency management
(3 times)
|
Emergency Medicine
(2 times)
|
ED (1 time)
GDH (1 time)
SGS (1 time)
|
2008 EDs are using 'GEMs' to improve elder care.
|
| 46 |
global energy minimum
(3 times)
|
Chemistry
(1 time)
|
eff (1 time)
GA (1 time)
HA (1 time)
|
1996 New theoretical methodology for elucidating the solution structure of peptides from NMR data. II. Free energy of dominant microstates of Leu-enkephalin and population-weighted average nuclear Overhauser effects intensities.
|
| 47 |
Goals for Eating and Moving
(3 times)
|
Clinical Trials as Topic
(1 time)
|
EUC (2 times)
PCMH (1 time)
VA (1 time)
|
2018 Development of a 5As-based technology-assisted weight management intervention for veterans in primary care.
|
| 48 |
gradient echo memory
(3 times)
|
Biology
(1 time)
|
QKD (1 time)
|
2008 Multimodal properties and dynamics of gradient echo quantum memory.
|
| 49 |
gas exchange monitor
(2 times)
|
Nutritional Sciences
(1 time)
|
ETT (1 time)
PIP (1 time)
VENT (1 time)
|
1988 Measuring infant metabolism: design and testing of a miniature gas exchange monitor.
|
| 50 |
Gaussian mixture-model with expectation maximization
(2 times)
|
Eye Diseases
(1 time)
|
CL (1 time)
FDT (1 time)
LR (1 time)
|
2014 Recognizing patterns of visual field loss using unsupervised machine learning.
|
| 51 |
Gel Bead in Emulsion
(2 times)
|
Biology
(1 time)
|
REXTAL (2 times)
|
2018 REXTAL: Regional Extension of Assemblies Using Linked-Reads.
|
| 52 |
gel-based emulsions
(2 times)
|
Chemistry
(2 times)
|
CsA (1 time)
SMEDDS (1 time)
|
2005 Novel gels and their dispersions--oral drug delivery systems for ciclosporin.
|
| 53 |
gemcitabine group
(2 times)
|
Neoplasms
(2 times)
|
LAPC (1 time)
|
2008 Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study.
|
| 54 |
gemcitabine triphosphate, dFdCTP
(2 times)
|
Nanotechnology
(1 time)
|
dFdU (2 times)
EPR (1 time)
HSA (1 time)
|
2017 Dual Enzymatic Reaction-Assisted Gemcitabine Delivery Systems for Programmed Pancreatic Cancer Therapy.
|
| 55 |
gemifloxacin mesylate
(2 times)
|
Physiology
(1 time)
|
LIN (1 time)
|
2014 Spectrofluorimetric determination of gemifloxacin mesylate and linezolid in pharmaceutical formulations: Application of quinone-based fluorophores and enhanced native fluorescence.
|
| 56 |
GEM + ZA-treated mice was significantly decreased compared to the control group
(2 times)
|
General Surgery
(1 time)
|
PDOX (1 time)
ZA (1 time)
|
2015 Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancer.
|
| 57 |
Genders extended model
(2 times)
|
Cardiology
(2 times)
|
AUC (2 times)
CAD (2 times)
IDI (2 times)
|
2017 Validation and comparison of four models to calculate pretest probability of obstructive coronary artery disease in a Chinese population: A coronary computed tomographic angiography study.
|
| 58 |
gene expression modulation
(2 times)
|
Biochemistry
(2 times)
|
---
|
2010 Discovering modulators of gene expression.
|
| 59 |
Gene, Environment and Methylation
(2 times)
|
Medical Informatics
(1 time)
|
EWAS (1 time)
methQTL (1 time)
|
2016 Gene, Environment and Methylation (GEM): a tool suite to efficiently navigate large scale epigenome wide association studies and integrate genotype and interaction between genotype and environment.
|
| 60 |
general effective media
(2 times)
|
Biophysics
(1 time)
|
YSZ (1 time)
|
2018 Applying the general effective media (GEM) approach for analyzing the thermal conductivity of ZrO2-8YSZ composites.
|
| 61 |
generalized elastic model
(2 times)
|
Biophysics
(2 times)
|
FLE (1 time)
|
2010 Correlations in a generalized elastic model: fractional Langevin equation approach.
|
| 62 |
generalized EM
(2 times)
|
Statistics as Topic
(1 time)
|
EM (1 time)
HMMs (1 time)
IOHMM (1 time)
|
1996 Input-output HMMs for sequence processing.
|
| 63 |
generalized empirical method
(2 times)
|
Ethics
(1 time)
|
---
|
2015 Palliative sedation, foregoing life-sustaining treatment, and aid-in-dying: what is the difference?
|
| 64 |
generalized Euler method
(2 times)
|
Biophysical Phenomena
(1 time)
|
MSGDTM (1 time)
|
2012 Fractional modeling dynamics of HIV and CD4+ T-cells during primary infection.
|
| 65 |
Genetic Evaluation of Men
(2 times)
|
Urology
(2 times)
|
GC (2 times)
GT (2 times)
PCa (2 times)
|
2018 Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.
|
| 66 |
genetically modified mouse
(2 times)
|
Urologic Diseases
(1 time)
|
MM (1 time)
MPM (1 time)
PDX (1 time)
|
2012 Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway.
|
| 67 |
geometrically enhanced mixing
(2 times)
|
Biochemistry
(1 time)
|
CTCs (2 times)
PD (1 time)
|
2014 Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip.
|
| 68 |
geriatric emergency medicine
(2 times)
|
Emergency Medicine
(2 times)
|
ED (2 times)
EM (1 time)
EP (1 time)
|
2018 White Paper-Geriatric Emergency Medicine Education: Current State, Challenges, and Recommendations to Enhance the Emergency Care of Older Adults.
|
| 69 |
global emergency medicine
(2 times)
|
Emergency Medicine
(2 times)
|
EDs (1 time)
EM (1 time)
IEMFC (1 time)
|
2014 Career paths and practice patterns of global emergency medicinephysicians: a cross-sectional survey.
|
| 70 |
Global Entrepreneurship Monitor
(2 times)
|
Cognitive Science
(1 time)
|
---
|
2017 A Lifespan Perspective on Entrepreneurship: Perceived Opportunities and Skills Explain the Negative Association between Age and Entrepreneurial Activity.
|
| 71 |
glucose-electrolyte mixture
(2 times)
|
Gastroenterology
(2 times)
|
---
|
1984 Comparison of two feeding regimens following acute gastroenteritis in infancy.
|
| 72 |
glycolipid- and cholesterol-enriched membrane
(2 times)
|
Biochemistry
(2 times)
|
---
|
1999 Incorporation of MAL, an integral protein element of the machinery for the glycolipid and cholesterol-mediated apical pathway of transport, into artificial membranes requires neither of these lipid species.
|
| 73 |
granulin/epithelin module
(2 times)
|
Biochemistry
(2 times)
|
---
|
2008 Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities.
|
| 74 |
grief evaluation measure
(2 times)
|
Health Services
(1 time)
|
---
|
2005 The grief evaluation measure (GEM): an initial validation study.
|
| 75 |
Grupo Espanol de Mieloma
(2 times)
|
Neoplasms
(2 times)
|
MM (2 times)
CR (1 time)
MM-PCs (1 time)
|
2012 Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients.
|
| 76 |
guanine-nucleotide exchange modulator
(2 times)
|
Natural Science Disciplines
(1 time)
|
CTCs (1 time)
FZD (1 time)
GPCRs (1 time)
|
2018 Prognostic Relevance of CCDC88C (Daple) Transcripts in the Peripheral Blood of Patients with Cutaneous Melanoma.
|
| 77 |
opportunities--Graduate Entry Medicine
(2 times)
|
Medicine
(2 times)
|
---
|
2011 Challenges & opportunities--Graduate Entry Medicine (GEM).
|
| 78 |
cancer-gemcitabine
(1 time)
|
General Surgery
(1 time)
|
PARP (1 time)
|
2007 Inhibition of proliferation by omega-3 fatty acids in chemoresistant pancreatic cancer cells.
|
| 79 |
copolymer-gemcitabine
(1 time)
|
Molecular Biology
(1 time)
|
HPMA (1 time)
i.p (1 time)
RAFT (1 time)
|
2017 Backbone Degradable N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates with Gemcitabine and Paclitaxel: Impact of Molecular Weight on Activity toward Human Ovarian Carcinoma Xenografts.
|
| 80 |
Ga-East Municipality
(1 time)
|
Medicine
(1 time)
|
---
|
2017 Factors influencing use of analgesics among construction workers in the Ga-Eastmunicipality of the Greater Accra region, Ghana.
|
| 81 |
galvanic eye movement
(1 time)
|
Otolaryngology
(1 time)
|
CGT (1 time)
GBS (1 time)
|
1991 Compensatory process of vestibular neuronitis. From findings of combined galvanic test and caloric test.
|
| 82 |
Gambling Experience Measure
(1 time)
|
Psychiatry
(1 time)
|
---
|
2006 Psychological experience of gambling and subtypes of pathological gamblers.
|
| 83 |
gas exchange measurement
(1 time)
|
Nutritional Sciences
(1 time)
|
DIT (1 time)
|
2014 Comparison of the GEM and the ECAL indirect calorimeters against the Deltatrac for measures of RMR and diet-induced thermogenesis.
|
| 84 |
Gas exchange monitoring
(1 time)
|
Anesthesiology
(1 time)
|
---
|
1992 [Validation of the gas exchange monitoring function of the Engstrom Elvira respirator].
|
| 85 |
gas expansion molding
(1 time)
|
Biomedical Engineering
(1 time)
|
AM (1 time)
CSCs (1 time)
ELDA (1 time)
|
2011 Enriching and characterizing cancer stem cell sub-populations in the WM115 melanoma cell line.
|
| 86 |
gaseous effluent monitor
(1 time)
|
Environmental Health
(1 time)
|
---
|
2018 Monte Carlo simulation of the responses of gaseous effluent monitors to radioactive isotopes.
|
| 87 |
Gaseous Electron Multiplier
(1 time)
|
Biomedical Engineering
(1 time)
|
AUG (1 time)
|
2016 Gaseous electron multiplier-based soft x-ray plasma diagnostics development: Preliminary tests at ASDEX Upgrade.
|
| 88 |
Gaussian effort model
(1 time)
|
Medical Informatics
(1 time)
|
---
|
2020 Patient asynchrony modelling during controlled mechanical ventilation therapy.
|
| 89 |
Gaussian elimination method
(1 time)
|
Radiotherapy
(1 time)
|
AB-IMRT (1 time)
CI (1 time)
FSA (1 time)
|
2011 A hybrid algorithm for instant optimization of beam weights in anatomy-based intensity modulated radiotherapy: A performance evaluation study.
|
| 90 |
Gaussian Evolutionary Method
(1 time)
|
Biochemistry
(1 time)
|
---
|
2002 GEM: a Gaussian Evolutionary Method for predicting protein side-chain conformations.
|
| 91 |
GCR exposure marker
(1 time)
|
Genetics
(1 time)
|
GCPR (1 time)
GCR (1 time)
GSM (1 time)
|
2018 Quantitative Proteomic Analysis of the Hippocampus of Rats with GCR-Induced Spatial Memory Impairment.
|
| 92 |
gelatin encapsulated microbubbles
(1 time)
|
Radiology
(1 time)
|
---
|
1982 Ultrasonic contrast enhancement of tissue by encapsulated microbubbles.
|
| 93 |
GEM +nab-PTX
(1 time)
|
Cell Biology
(1 time)
|
nab (1 time)
PDOX (1 time)
|
2018 Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models.
|
| 94 |
GEM +S. typhimurium A1-R
(1 time)
|
Cell Biology
(1 time)
|
nab (1 time)
PDOX (1 time)
|
2018 Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models.
|
| 95 |
Gem GTPase
(1 time)
|
Veterinary Medicine
(1 time)
|
AM (1 time)
CALB1 (1 time)
KU (1 time)
|
2003 Analyses of beta-1 syntrophin, syndecan 2 and gem GTPase as candidates for chicken muscular dystrophy.
|
| 96 |
GEM+rMETase
(1 time)
|
Cell Biology
(1 time)
|
PDOX (1 time)
rMETase (1 time)
|
2018 Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.
|
| 97 |
Gem-associated protein 2-like isoform X1
(1 time)
|
Chemistry
(1 time)
|
bp (1 time)
dsRNA (1 time)
Mn-IAG (1 time)
|
2019 Potential Functions of Gem-Associated Protein 2-Like Isoform X1 in the Oriental River Prawn Macrobrachium nipponense: Cloning, qPCR, In Situ Hybridization, and RNAi Analysis.
|
| 98 |
gemcitabine (GEM)/ docetaxel (DOC)
(1 time)
|
Cell Biology
(1 time)
|
iPDOX (2 times)
CPA (1 time)
DOC (1 time)
|
2017 Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) model.
|
| 99 |
Gemcitabine 2',2'-difluoro 2'-deoxy cytosine
(1 time)
|
Chemistry
(1 time)
|
Cyt (1 time)
|
1996 Ab initio quantum mechanical and X-ray crystallographic studies of gemcitabine and 2'-deoxy cytosine.
|
| 100 |
gemcitabine treatment
(1 time)
|
Neoplasms
(1 time)
|
AHCC (1 time)
CRP (1 time)
mGPS (1 time)
|
2016 Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.
|
A Search Service for Abbreviation / Long Form